The state of California is teaming up with the nonprofit generic drug maker Civica Rx and Biocon Biologics to offer an interchangeable biosimilar insulin glargine pen for $11 beginning January 1, 2026 ...
(n){if(!window.cnxel){window.cnxel={},window.cnxel.cmd=[];var t=n.createElement('iframe');t.src='javascript:false'; t.display='none',t.onload=function(){var ...
Californians with diabetes will soon have access to a low-cost insulin pen as part of a new state initiative announced today, October 16, by Gov. Gavin Newsom.Beginning Jan. 1, 2026, CalRx-branded ...
The state’s insulin — sold under the brand name CalRx — will be available at a recommended price of $11 per pen, or $55 for a five-pack. The move is part of a partnership between the state and the ...
Biocon Biologics recently announced that it would manufacture and supply insulin glargine pens to Civica under a multi-year ...
California has launched a program to manufacture and sell lower-cost insulin to people with diabetes. State officials say ...
Starting in the new year, insulin pens will be available at a recommended price of $11 per pen, or a maximum of $55 for a five-pack ... It is one piece of California's effort to lower prescription ...
As the first and only state contracting for its own affordable insulin, Governor Gavin Newsom announced Oct. 16 that CalRx® ...
California will start selling a generic version of glargine at a recommended price of $11 per pen, or $55 for a five-pack, January 1.
France’s highest court on Wednesday rejected an appeal by far-right leader Marine Le Pen, dealing a major setback to her efforts to overturn a sentence that could bar her from running in the 2027 ...
Geneva -- The World Health Organization sounded the alarm Monday over soaring numbers of drug-resistant bacterial infections, compromising the effectiveness of life-saving treatments and rendering ...
PARIS, Oct 9 (Reuters) - After falling short of a majority in last year's snap legislative vote, French far-right leader Marine Le Pen said her party's victory had merely been delayed. Fifteen months ...